The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe
Nucleic Acids Research · 20.06.2025 · 53 (12)
DOI: 10.1093/nar/gkaf573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 25.06.2025. Verfasst von Jinal A Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, United States. Hauptthemen laut MEDLINE: DNA Replication, Tumor Suppressor Protein p53, DNA-Activated Protein Kinase, Apoptosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH Shared Instrument Grant.
Abstract (Originalsprache)
Exacerbating the DNA replication problems of cancer cells serves as a viable therapeutic approach. Nevertheless, the cytotoxicity of cancer drugs is often hampered by therapy-induced senescence, leading to unfavorable patient outcomes. Here, we employ acute replisome dysfunction in combination with Ataxia telangiectasia and Rad3-related (ATR) inhibition as a strategy to divert senescent cells toward death by triggering DNA replication catastrophe, a form of irreversible replication fork collapse caused by excessive single-stranded DNA (ssDNA) accumulation. RNA-sequencing revealed a distinct set of p53-responsive genes responsible for death. We identify c-Jun N-terminal kinase (JNK) to be essential for augmenting p53-dependent apoptotic programs and inducing pan-nuclear distribution of γH2AX, together constituting a feed-forward loop to drive cell death. Activation of DNA-PKcs initiates the signaling cascade of replication catastrophe, including CHK1-dependent JNK activation, which relies on MRE11 and PARP1 to expand and recognize ssDNA gaps, defining replication-associated gaps as an underlying basis for replication catastrophe. Our study elucidates the dynamic regulation of proximal and distal effectors along the DNA-PKcs/JNK/p53 axis that govern the cell fate decision between senescence and death. We propose that key determinants of replication catastrophe signaling are targetable vulnerabilities that can be exploited to limit senescent cell populations and increase the efficacy of anti-cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacological Sciences, State University of New York at Stony Brook, Stony Brook, NY 11794, United States.
- Stony Brook Cancer Center, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, United States.
ORCID-Profile: Hyungjin Kim
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIH Shared Instrument Grant
- National Institutes of Health
- Center for Healthy Aging
- Stony Brook University OVPR research
- Renaissance School of Medicine
- American Cancer Society Institutional Research
Zitieren
APA
Patel, J. A., Rageul, J., Lo, N., Nandi, A., Zezelic, C., Lee, C. T., Khan, A., & Kim, H. (2025). The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe. Nucleic Acids Research, 53(12). https://doi.org/10.1093/nar/gkaf573
Vancouver
Patel JA, Rageul J, Lo N, Nandi A, Zezelic C, Lee CT, et al. The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe. Nucleic Acids Research. 2025;53(12). doi:10.1093/nar/gkaf573
BibTeX
@article{Patel2025,
author = {Patel, Jinal A and Rageul, Julie and Lo, Natalie and Nandi, Auntara and Zezelic, Camryn and Lee, Cynthia T and Khan, Arafat and Kim, Hyungjin},
title = {The DNA-PKcs/JNK/p53 pathway underlies changes in cell fate decision toward death during DNA replication catastrophe},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {12},
doi = {10.1093/nar/gkaf573}
}
EUVIMED